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Abstract— Objective: We describe and evaluate an automated 
software tool for nerve fibre detection and quantification in 
corneal confocal microscopy (CCM) images, combining sensitive 
nerve-fibre detection with morphological descriptors. Method: 
We have evaluated the tool for quantification of Diabetic 
Sensorimotor Polyneuropathy (DSPN) using both new and 
previously published morphological features. The evaluation 
used 888 images from 176 subjects (84 controls and 92 patients 
with Type 1 diabetes). The patient group was further subdivided 
into those with (n=63) and without (n=29) DSPN. Results: We 
achieve improved nerve-fibre detection over previous results 
(91.7% sensitivity and specificity in identifying nerve-fibre 
pixels). Automatic quantification of nerve morphology shows a 
high correlation with previously reported, manually measured, 
features. ROC analysis of both manual and automatic 
measurement regimes resulted in similar results in distinguishing 
patients with DSPN from those without: AUC of about 0.77 and 
72% sensitivity-specificity at the equal error rate point. 
Conclusion: Automated quantification of corneal nerves in CCM 
images provides a sensitive tool for identification of DSPN. Its 
performance is equivalent to manual quantification, while 
improving speed and repeatability. Significance: Corneal 
confocal microscopy is a novel in-vivo imaging modality that has 
the potential to be a non-invasive and objective image biomarker 
for peripheral neuropathy. Automatic quantification of nerve 
morphology is a major step forward in the early diagnosis and 
assessment of progression, and, in particular, for use in clinical 
trials to establish therapeutic benefit in diabetic and other 
peripheral neuropathies. 
 
Index Terms— Diabetic Sensorimotor Polyneuropathy, 
Computer Aided Diagnosis, Corneal Confocal Microscopy, Image 
Analysis, Nerve Fibre Quantification 
 
I. INTRODUCTION 
IABETIC sensorimotor polyneuropathy (DSPN) is one of 
most common long term complications of diabetes. Up to 
 
 J. Graham is with the Centre for Imaging Sciences, the University of 
Manchester, UK. E-mail: jim.graham@manchester.ac.uk 
 X. Chen is now at the Division of Imaging Sciences and Biomedical 
Engineering, Kings College London, UK. E-mail: xin.chen@kcl.ac.uk 
 M. Dabbah is currently at Roke Manor Research Ltd. Romsey, UK 
 I. Petropoulos, M. Tavakoli and Rayaz Malik are with Centre for 
Endocrinology & Diabetes, Institute of Human Development, Manchester, 
UK. I. Petropoulos and Rayaz Malik are also with Weill Cornell Medical 
College in Qatar, Division of Medicine, Doha, Qatar. 
Copyright (c) 2016 IEEE. Personal use of this material is permitted. However, 
permission to use this material for any other purposes must be obtained from 
the IEEE by sending an email to pubs-permissions@ieee.org. 
50% of diabetic patients suffer from it [1], and it is estimated 
that about one in six diabetic patients have chronic painful 
neuropathy [2]. Several methods are currently used to quantify 
neuropathy, including clinical scoring of symptoms, 
quantitative sensory testing, nerve conduction measurements 
and microscopic measurement of intra-epidermal nerve-fibre 
density (IENFD) in skin biopsy samples. These methods have 
their advantages and limitations. Thus, whilst symptoms and 
signs are directly relevant to the patient and are easily 
recorded, they are subjective resulting in poor repeatability 
[3]. Neurophysiology is more objective; however it only 
assesses large fibres, which constitute a tiny proportion of all 
the nerve fibres present in a peripheral nerve and has also been 
shown to have limited reproducibility [4]. The quantification 
of IENFD in skin biopsies is objective, but is clearly invasive 
and requires considerable expertise in assessment.  There is a 
need for a rapid, non-invasive assessment that is truly 
quantitative and assesses small nerve fibres, which are more 
likely to be involved in neuropathy [5, 6].  
      Corneal confocal microscopy (CCM) images of nerve 
fibres are captured from the sub-basal plexus immediately 
above Bowman’s membrane of the cornea by an in-vivo laser 
confocal microscope. Fig. 1a shows an example image. One of 
the advantages of CCM is the entirely non-invasive and 
relatively rapid (about 2 minutes) acquisition of images of 
small nerve fibres and other corneal structures. Clinical studies 
[7] have shown that CCM is capable of making quantitative 
assessment of DSPN and has the potential to be an ideal 
surrogate endpoint. It has also recently been shown to have a 
predictive ability in identifying diabetic patients at risk of 
developing DSPN [8] and has been used in several clinical 
intervention studies showing nerve-fibre repair [9-11]. 
Interactive analysis has been used to derive measurements 
from these images, such as corneal nerve-fibre length (CNFL), 
corneal nerve-fibre density (CNFD) and corneal nerve branch 
density (CNBD) [12, 13] (Fig. 1). CNFL is defined as the total 
length of all nerve fibres visible in the CCM image per square 
millimetre. CNFD and CNBD are the number of the major 
nerves (red lines in Fig. 1b) per square millimetre and the 
number of primary branches emanating from those major 
nerve trunks (green dots in Fig. 1b) per square millimetre 
respectively. Although an association has been demonstrated 
between these quantitative features and the severity of DSPN 
[7] in cross sectional studies, the manual analysis suffers from 
the usual problems of being labour-intensive and subjective 
and therefore raises considerable difficulties, particularly 
when undertaking longitudinal follow-up studies [14]. 
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Consequently the quantification results show poor 
reproducibility, especially in CNBD [15]. For the technology 
to be clinically useful, the analysis of images needs to be done 
automatically. 
Here we describe a fully automatic nerve-fibre detection 
and quantification system. Fig. 1a indicates that the 
appearance of nerve fibres in CCM images covers a wide 
contrast range, with some fibres appearing very faint on a 
noisy background, whilst other, larger, fibres show strong 
contrast. A number of studies have presented methods of 
detecting similar linear structures in different types of images 
e.g. the detection of blood vessels in retinal images [16], and 
the detection of curvilinear structure in mammograms [17]. 
Previous studies aimed at automatic fibre detection in CCM 
images include Scarpa et al. [18] who described a method for 
tracing nerve fibres based on automatically initialised seed 
points, and Holmes et al. [19]who identified fibres based on 
ridge points. Sindt et al. [20] detected several types of objects 
visible in CCM images, including dendritic immune cells and 
wing cells in addition to nerve fibres. Dabbah et al. [21] 
presented a method of fibre detection based on a multi-scale 
Gabor filter with responses trained using a neural network. 
The best detection performances in various applications are 
achieved using methods based on machine learning, in which 
features are derived from training images [16, 17, 21]. 
      Following fibre detection, it is required to extract 
individual fibres, identify branches and quantify appropriate 
features for classification. A number of studies have 
investigated the quantification of a variety of image features, 
describing the morphology of nerve fibres delineated either 
manually or automatically [13, 19-21]. These studies have 
shown the relationship between several features, including 
those listed above, and neuropathic status. None of them, 
however, has addressed the question of diagnosis of individual 
subjects.  
      We have previously described our image filter for 
enhancing nerve-fibre pixels [21] and reported clinical results 
of applying this system to DSPN [22]. This paper describes 
the development of the fibre detection method into a complete 
tool for measurement of nerve-fibre morphology to act as a 
diagnostic aid, making three specific contributions over our 
earlier publications: (1) we compare our fibre detector [21] 
with another, successful, linear feature descriptor and 
demonstrate the best reported performance in detecting nerve-
fibre pixels in CCM images. (2) The detailed algorithms for 
quantification of morphometric features are presented for the 
first time (only CNFL was used in [21]), including the 
established features (CNFD, CNFL, CNBD) and new features: 
Corneal Nerve-Fibre Width Histogram (CNFWH) and Corneal 
Nerve-Fibre Orientation Histogram (CNFOH). (3) Finally, we 
report a technical validation of the proposed system based on 
CCM images obtained from 84 control subjects and 92 type 1 
diabetic patients, which, to our knowledge, is the largest 
dataset in the literature for DSPN diagnosis of individuals. 
II. METHODS 
A. CCM Images and Manual Measurement 
CCM images (Fig. 1(a)) were captured from all participants using 
the Heidelberg Retina Tomograph Rostock Cornea Module (HRT-
III) as described in [13]. The image dimensions are 384×384 
pixels with the pixel size of 1.0417μm. During the CCM scan, 
images captured from all corneal layers and six sub-basal images 
from the right and left eyes were selected for analysis. Criteria for 
image selection were depth, focus position and contrast. A single 
experienced examiner, masked from the outcome of the medical 
and peripheral neuropathy assessment, manually quantified 
images of all study participants using purpose-written proprietary 
software (CCMetrics: M. A. Dabbah, Imaging Science, University 
of Manchester) to delineate main fibres, branch fibres and branch 
points (red lines, blue lines and green dots respectively in Fig. 
1b). The reproducibility and reliability of manual annotation are 
reported in [15].The specific parameters measured in each frame 
were_ENREF_18: CNFD, CNFL and CNBD, as described in 
section I in accordance with our previously published protocol 
[13]. 
B. Automated CCM Measurement 
The automated CCM measurement process consists of two 
main steps: nerve-fibre detection and nerve-fibre 
quantification. 
 
1)  Nerve-Fibre Detection: 
In this and similar applications [16, 17], methods based on 
machine learning have been reported to outperform others in 
detection of curvilinear features. The machine learning method 
normally consists of two key elements, feature description and 
classifier training on a set of samples.  
 
                                                        (a)                                                                 (b)                                                                      (c) 
Fig. 1. (a) Original CCM image. (b) Manually quantified CCM image. (c) Automatically quantified CCM image. Red lines represent main nerve fibres, blue 
lines are branches and green spots indicate branch points on the main nerve trunks. Refer to online coloured version. 
0018-9294 (c) 2016 IEEE. Personal use is permitted, but republication/redistribution requires IEEE permission. See http://www.ieee.org/publications_standards/publications/rights/index.html for more information.
This article has been accepted for publication in a future issue of this journal, but has not been fully edited. Content may change prior to final publication. Citation information: DOI 10.1109/TBME.2016.2573642, IEEE




For the feature description process, we have implemented 
and adapted two of the most successful methods [17, 21] for 
representing curvilinear structures. Dabbah et al. [21] 
proposed a multi-scale “dual-model filter” (DMF) that 
combines a foreground model based on a Gabor wavelet with 
a Gaussian background model that scales the output according 
to the level of noise. In our implementation, we apply the 
DMF at eight orientations (suggested in [21]) and at four 
levels of an image pyramid. Each level is a down-sampled 
(with smoothing) version of its immediate higher level by a 
factor of 2. The Gabor wavelet and Gaussian filter covered 
orientations from 0° to 180° and a range of fibre widths that 
we found to be sufficient for the CCM images in our study. 
The DMF method results in 32-dimensional vectors (8 
orientations × 4 scale pyramid levels) to describe features at 
each pixel location. 
Berks et al. [17] described a system that used the dual-tree 
complex wavelet transform (DWT) [23] for detection of linear 
structures in mammograms. The DWT combines the outputs 
of two discrete transforms, using real wavelets differing in 
phase by 90°, to form the real and imaginary parts of complex 
coefficients. It provides a directionally selective representation 
with approximately shift-invariant coefficient magnitudes and 
local phase information. As in the DMF method, the DWT is 
applied to a four-level image pyramid. Additionally, the DWT 
is performed at six different orientations (±15°, ±45°, ±75°, 
used in [17]) at each pyramid level. The six sub-bands are then 
multiplied by {i, -i, i, -1, 1, -1} respectively, so that the phase 
at the centre of the impulse response of each wavelet is zero. 
Finally, to achieve 180° rotational symmetry, any coefficient 
with negative imaginary part is replaced with its complex 
conjugate. Hence from coarse level to fine level of the image 
pyramid, the DWT results in a 48-element feature vector (4 
level image pyramid × 6 orientation × 2 magnitude and phase) 
for each selected pixel location. Both of these detectors 
outperformed competitors in their respective domains.   
In this study we have implemented both detectors in the 
form proposed by the original authors (number of pyramid 
levels and orientations) as these produced feature vectors of 
similar dimension. We then subjected them to a comparative 
analysis in detecting nerve fibres. 
For classifier training, the feature descriptors and their 
corresponding fibre/non-fibre labels from a set of training 
samples were used as the inputs to a classifier, which took the 
form of either a neural network or random forest [24]. The 
trained classification model was then used for classifying 
fibre/non-fibre pixels in unseen CCM images. 
CCM images have a fairly high level of background noise 
(see Fig. 2a), which at a fine scale have similar contrast to 
nerve fibres at random orientations. These may be detected by 
the trained detectors and are removed by a further denoising 
step, which iteratively diminishes pixels that are not consistent 
with the dominant direction over a localised region. The 
output response image after denoising is shown in Fig. 2b. The 
 
            (a)                                                                     (b)                                                                      (c) 
 
                                                     (d)                                                                    (e)                                                                      (f) 
Fig. 2. (a) Original CCM image (b) Response image after nerve-fibre detection and denoising (c) Nerve-fibre skeleton with highlighted weak connection 
segments (d) Nerve-fibre skeleton after assessment of weak connections. (e) Automatically detected end points (hollow circles) and intersection points (solid 
circles). (f) Final detected nerve fibres. 
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evaluation and comparison of different combinations of the two 
feature descriptors and the two classifiers, before and after 
denoising, are presented in section III.  
Based on the denoised image, a threshold is then applied to 
generate a binary image. The optimum threshold value is 
determined by the training and validation experiments 
described in section III-A. The binary image is then filtered by 
morphological operators to fill small gaps within nerve fibres 
and link adjacent structures. The binary structures are thinned 
to obtain a one-pixel wide skeleton (Fig. 2c). Branch and end 
points, identified by counting the neighbours of each skeleton 
point, are each assigned a unique label. For some regions, the 
evidence for nerve fibres is too weak (as highlighted in Fig. 
2c) to be detected by a global threshold. However, the 
undetected pixels may be important in determining the nerve-
fibre connectivity. Hence, for each end point, we extrude 30 
pixels along the fibre orientations. The orientation of nerve 
fibres at each pixel location can be estimated using the second 
eigenvalue of the Hessian matrix of the response image. If an 
intersection with another fibre is detected and the average 
probability from the response image of the extruded pixels is 
sufficiently high (> 0.2), the extruded line is retained, 
otherwise it is eliminated (Fig. 2d). Subsequently, independent 
small segments and short branches that are less than 15 pixels 
long are removed, and the intersection points (solid circles) 
and end points (hollow circles) are calculated again as shown 
in Fig. 2e. The final binary skeleton, as shown in Fig. 2f, is 
used for total nerve-fibre quantification, described in the next 
section.  
 
2) Nerve-Fibre Quantification 
Fig. 2f shows that the output of fibre detection consists of 
several networks of interconnected line segments. In order to 
produce similar results to the manual CNFD, CNFL and 
CNBD, it is important to identify the main fibres within these 
networks and the branch points along the main fibres. To 
connect the appropriate fibre segments together, we generate 
four N × N matrices (MI, ML, MW and MO) to store the fibre 
intensity, fibre length, fibre width (described later in this 
section) and fibre orientation information respectively for each 
segment. N is the total number of branch and end points. If the 
ith and jth end/branch points are connected by a segment, the 
intensity, width, length and orientation information will be 
saved at the [i, j] location of the corresponding matrices; if 
they are not connected, these elements are zero. The matrices 
of intensity (MI), length (ML) and width (MW) are 
symmetric, as the elements at [i, j] and [j, i] should be 
identical. The [i, j] and [j, i] elements in the orientation matrix 
MO represent the respective orientations of the opposite ends 
of the fibre segment.  
Identification of the main nerve fibres starts with the most 
prominent segments: those with greatest length and width. 
These are identified by multiplying the corresponding 
elements of MW and ML to produce a new matrix MA. The 
segments are considered in sequence according to the 
corresponding values of MA in descending order. There are 
normally two candidate segments that intersect with the 
current segment at a branch point. The candidate segments are 
ranked for the length, orientation difference, intensity and 
width parameters respectively. The candidate with the highest 
summed rank is chosen to connect with the current segment. 
The process continues till an end point is reached. The 
relevant entry in MA is set to zero and the process continues 
until no non-zero elements remain in MA. Finally, a list of 
connected fibres is obtained. Only the fibres with length 
greater than a threshold are kept as the main fibres. Fig. 1b 
and 1c respectively show the manual and automatic 
quantification results of the CCM image in Fig. 1a. The red 
lines show the principal nerve fibres, which are counted to 
produce CNFD. The blue lines indicate the secondary nerve 
fibres, which together with the principal fibres make up 
CNFL. The green dots are the branch points from the main 
fibres that are used for CNBD calculation.  
Besides the CNFD, CNFL and CNBD features that are 
readily measured in the manual analysis, automatic 
quantification is able to calculate additional features. These 
additional CCM features include the total corneal nerve-fibre 
area per mm2 (CNFA), the corneal nerve-fibre width 
histogram (CNFWH) and the corneal nerve-fibre orientation 
histogram (CNFOH). These can be calculated if the width and 
orientation at each nerve-fibre location is known. The 
orientation is calculated by the Hessian method referred to in 
section II-B-1. The nerve-fibre width estimation for a 
particular segment is illustrated in Fig. 3. Fig. 3a shows a 
highlighted example nerve-fibre segment along with a 
           
                                          (a)                                                                         (b)                                                                            (c) 
Fig. 3. (a) Original CCM image with a highlighted segment, a selection of orthogonal profile lines are indicated on the enlarged inset.  Profiles are calculated at 
each pixel along the segment. (b) Average of all the profile lines along the whole fibre segment. (c) The symmetric profile of (b) is firstly calculated, and then 
normalised (Solid line). A Gaussian distribution is fitted for nerve-fibre width estimation (broken line). The final width equals 2.5 times the RMS width (σ) of the 
fitted Gaussian curve.   
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Fig. 4. ROC curves for nerve-fibre detection on dataset 2, using 
DMNN (Dual Model, Neural Network), DMRF (Dual Model, Random 
Forest), DTNN (Dual-Tree Wavelet, neural Network) and DTRF 
(Dual-Tree Wavelet, Random Forest) respectively. 
magnified version. At each nerve-fibre location, an intensity 
profile line of length 13 pixels (larger than the thickest fibre) 
is extracted perpendicular to the nerve-fibre orientation, as 
indicated by the short straight lines in Fig. 3a. The profiles 
corresponding to a fibre segment are averaged along the length 
of the segment to generate a representative profile for the 
segment, which is then further averaged (Fig. 3b) with its 
symmetrically inverted profile, smoothed by a three pixel 
length average filter and normalised (Fig. 3c). Finally a 
Gaussian curve is fitted to the normalised profile curve (Fig. 
3c). The final width of that segment is calculated as 2.5 
(empirically determined) times the RMS width of the fitted 
Gaussian curve. CNFWH is the number of occurrences of 
different fibre widths in the range between 1 to 8 pixels, at 0.2 
pixels interval (36 bins). The CNFA is calculated as sum of 
fibre width × fibre length of all the fibre segments in mm2. 
The CNFOH is the number of occurrences of different fibre 
orientations in the range between 0° to 179°, at 5 degree 
interval (36 bins). 
III. MATERIALS AND EVALUATION 
We performed the model training and testing processes on two 
independent datasets. Dataset 1 contains 200 CCM images 
which were randomly selected from healthy volunteers and 
subjects who were diagnosed with type 1 diabetes. This 
dataset was used for model training and validation for 
parameter optimisations. The testing stage was conducted on 
an independent dataset 2 that contained 888 images captured 
from 176 subjects (84 controls and 92 diabetic patients). The 
subjects were divided into 3 groups: control (n=84), type 1 
diabetic patient with no neuropathy (n=63) and diabetic 
patients with neuropathy (n=29). The Toronto Diabetic 
Neuropathy Expert Group (TC) [6] recommendation was 
followed to define an individual to have DSPN if he/she met 
both of the following criteria: (1) Abnormal nerve conduction 
– A peroneal motor nerve conduction velocity of <42 m/s; (2) 
a symptom or sign of neuropathy, defined as ONE of the 
following: (a) diabetic neuropathy symptom (DNS) [25] of 1 
or more out of 4, (b) neuropathy disability score (NDS) [26] of 
3 or more out of 10. These features, along with a number of 
other clinical and physiological parameters, were measured for 
each subject [22]. 
Following the description in section II-A, all images from 
both dataset 1 and dataset 2 were acquired by the same 
procedure. They were all manually segmented by a trained 
clinician (INP). CNFD, CNFL and CNBD were also measured 
manually in each of the images using the CCMetrics 
annotation tool (denoted as MCNFD, MCNFL, and MCNBD, 
respectively). 
 
A. Evaluation of Nerve-Fibre Detection 
For the evaluation of nerve-fibre detection, we firstly trained 
and validated the models based on dataset 1 using a two-fold 
cross validation. The 200 images in dataset 1 were randomly 
divided into two groups with 100 images each. Each set served 
for parameter setting and training based on the other half as a 
test set.  The roles were then reversed. We performed this two-
fold cross validation on the four combinations of feature 
descriptors (DMF and DWT) and model classifiers [24] (random 
forest (RFC) and multi-layer perceptron neural network classifiers 
(NNC)), denoted as DMRF (DMF + RFC), DMNN (DMF + 
NNC), DTRF (DWT + RFC) and DTNN (DWT + NNC). For 
each of the combinations, we repeated the two-fold cross 
validation to investigate the optimum parameter settings by 
varying the number of training pixels (500, 1000, 2000 pixels 
randomly selected from each of the foreground and background 
regions for each image), the number of trees (100, 200 and 500 
trees) in RFC and the number of hidden neurons (20, 50 and 100) 
in the three-layer NNC.  
For performance evaluation, as in [21], the response images 
(before denoising) were thresholded and thinned to one-pixel 
wide lines. These lines were then compared pixel by pixel to 
the manually generated skeletons acting as ground-truth, a true 
positive (TP) being scored if the detected pixel is within a 
three-pixel tolerance of ground truth and a false positive (FP) 
if it is outside this tolerance. True negative (TN) and false 
negative (FN) pixels are recorded if the pixel in the detected 
image is zero while the ground-truth is zero and one 
respectively. The three pixel tolerance deals with the 
imprecision in placing hand-drawn centrelines. By varying the 
threshold of the response images, ROC curves can be 
generated for each of the parameter settings. Optimum 
performance, in terms of specificity and sensitivity at the 
equal error rate point and computational time, was achieved 
by using 1000 foreground and background pixels from each 
image for training, and 200 trees for RFC and 50 hidden 
neurons for NNC. 
In the testing stage, we applied the two optimised models 
(one from each of the two-fold cross validation runs on dataset 
1) to the independent dataset 2. ROC performances were 
compared between models trained using DMNN, DMRF, 
DTNN and DTRF. The values of sensitivity and specificity at 
the equal error rate point for the two models were as follows. 
DMNN: 0.917 and 0.913, DMRF: 0.912 and 0.908, DTNN: 
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FDR AND FNR FOR THE FOUR COMPARED DETECTORS 






DMNN 0.4810/0.2700 0.2013/0.2934 
DMRF 0.4828/0.2877 0.2014/0.2983 
DTNN 0.4890/0.2961 0.2012/0.3141 
DTRF 0.4881/0.3221 0.2013/0.3261 
 
0.888 and 0.882, DTRF: 0.883 and 0.878. In Fig. 4, we show 
the ROC plots of the model that with the higher performance. 
These were obtained using the raw detections before denoising 
to obtain an insight into the underlying detector performance. 
From the ROC curves, it is clear that the combination based 
on the DMF outperforms the DTW feature descriptor, having 
higher sensitivity at any value of specificity. 
    Although the specificity is a fair measurement for the 
detection of both background and foreground pixels, the value 
is dominated by the very high TN count. The absolute value of 
specificity is potentially misleading, as we have noted in 
section II-B-1 that the initial detection results in detection of a 
high number of background pixels that are removed by a 
subsequent denoising step. We therefore also calculated the 
False Discovery Rate (FDR=FP/ (FP+TP)) and the False 
Negative Rate (FNR=FN/ (FN+TP)). The smallest (best) 
FDR/FNR measures for the four methods before and after 
image denoising are listed in Table I. Since the two cross 
validation models produce very similar classifications, we 
only report the results from one of the cross validation models. 
All four detector/classifier combinations have similar FDR 
values before denoising and, significantly reduced, after 
denoising, consistent with the similar specificity values at 
most values of sensitivity in Fig. 4. The FNR values increase 
only slightly by denoising, the DM detector achieving better 
FNR figures. Following denoising there is no real difference 
between the RF and NN classifiers. 
B. Evaluation of Nerve-Fibre Quantification 
As observed in section III-A the two cross-validation 
models produced very similar performance on the 
independent dataset 2.  We chose the detector model with 
the slightly higher performance as the basis for automated 
measurements of nerve-fibre parameters, denoted ACNFD, 
ACNFL and ANCBD.  Additionally, total nerve-fibre area, 
orientation histogram and width histogram were calculated 
(CNFA, CNFOH ad CHWH).  For the multidimensional 
features CNFOH and CNFWH, we investigated the use of the 
maximum, standard deviation, skewness, kurtosis and logistic 
regression combing all elements of the histogram feature 
vectors to represent the feature. The standard deviation of the 
histogram proved to be the most effective; these are denoted as 
ASDOH and ASDWH. 
For each of the subjects, the average feature values obtained 
from their CCM images were used. Fig. 5 and Fig. 6 show the 
box plots of each of the manual and automated CCM features 
respectively. In these figures, the central red lines are the 
median, the edges of the box are the 25th and 75th percentiles 
(q1 and q3), and the whiskers extend to the most extreme data 
points that are not identified as being outliers (within the range 
q1-1.5(q3-q1) to q3+1.5(q3-q1)). The outliers are plotted 
individually as red dots. A common decreasing trend from 
control group to neuropathy group can be observed on all 
manual and automated CCM features. The values of the 
manually generated measurements are higher than those 
generated automatically. One reason for this is that the manual 
tracing process deviates from the exact fibre path (Fig 1(b)), 
resulting in a larger CNFL value. Additionally, the automated 
method is less effective than human annotators at connecting 
weak branches, resulting in generally higher CNFD and 
CNBD values for the manual analysis. However, the important 
point is the relative correlation between manual and automated 
measures across the control and patient groups. The Pearson 
correlation coefficients between automatically and manually 
derived CNFL, CNFD and CNBD measurements were 0.861, 
0.859 and 0.701 respectively. The lower correlation in the case 
of CNBD measurement is due to poor reproducibility in the 
manual measurement of this feature. This has been reported in 
[15] and arises from the subjective judgement required for 
identifying branch points. 
We used both the ANOVA test [27] and ROC analysis to 
demonstrate the capability of using the CCM image features to 
discriminate between control and non-neuropathic groups, and 
between non-neuropathic and neuropathic patients, as defined 
by the Toronto Criteria.   
Tables II and III show the respective ANOVA p-values, the 
area under the ROC curve (AUC) measures and sensitivity and 
specificity values calculated at the equal error point (EEP) of 
the ROC curves. We also experimented with different 
combinations of features, from both manual and automated 
analysis, using logistic regression in a leave-one-out manner. 
In these experiments each subject was predicted by the logistic 
regression model built from the remaining n-1 subjects, where 
n is the total number of subjects in both groups. ROC 
measures for the combinations of all manual features or all 
automated features are listed in Table II and Table III along 
with the single-feature measures. The confidence intervals for 
the combined methods indicate that the combination results in 
a discriminating power indistinguishable from the best manual 
or automatic methods respectively. This would indicate that 
the features are accessing the same underlying information 
about each of the groups. It is unsurprising that there should 
be dependency between total fibre length and fibre density or 
fibre area.  
IV. DISCUSSION 
A number of studies have shown the features extracted from 
Corneal Confocal Microscopy images are associated with the 
severity of diabetic peripheral neuropathy [7, 12, 13] and the 
potential of CCM to quantify severity of neuropathy and 
assess therapeutic benefit has been demonstrated [28]. In this 
paper, we have described the details of a complete system for 
measurement of CCM images to enable discrimination 
between control and diabetic subjects and between diabetic 
subjects with and without neuropathy. 
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Petropoulos et al. [22] reported a clinical evaluation study 
comparing the system described in this paper with manual 
analysis of CCM images and a broader range of subjective and 
objective clinical assessment methods, including the 
Neuropathy Symptom Profile, vibration perception thresholds, 
cool and warm thermal thresholds, and cold and heat induced 
pain. CCM features, measured both automatically and 
manually, were found to be significantly correlated with these 
methods. They noted that the automatic analysis of CCM 
images was significantly faster than manual analysis, taking 
10-22s per image, depending on the density of fibres, as 
opposed to 2-7 minutes.  
Based on the well-established Toronto Criteria, we show 
that both manual and automated CCM features discriminate 
diabetic patients with and without neuropathy. Manual and 
automatic measurement regimes result in broadly similar 
results: about 0.77 AUC value and 73% sensitivity-specificity 
at the equal error rate point. There were no significant 
differences between the ROCs of manual (MCNFD) and 
automated measurements (e.g. p=0.44 and 0.55 for ACNFD 
and SDWH respectively).  
Corneal confocal microscopy has shown considerable 
success in translation to the assessment of other neuropathies 
including Fabry disease [29], ISFN [30], CMT1A [31], 
sarcoidosis [32]. Automated quantification of corneal nerves 
provides a major step forward in the early diagnosis and 
assessment of progression, but in particular for use in clinical 
trials to establish therapeutic benefit in diabetic and other 
peripheral neuropathies.  
The automatic quantification software can be requested 
freely from [33] for research purposes. It is currently being 
used by over 40 research groups worldwide to investigate 
potential relationships between CCM features and different 
types of neuropathy [34]. 
V. CONCLUSION 
We have presented a technical evaluation of a complete 
system that is able to automatically quantify six different types 
of nerve-fibre features in CCM images. We have proposed an 
optimum configuration for detection of nerve fibres based on a 
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Fig. 6. Boxplots of automatically measured features for control, non-neuropathy and neuropathy groups in dataset 2 (a) ACNFD (b) ACNFL (c) ACNBD (d) 
ACNFA (e) ASDOH (f) ASDWH. 
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previously reported foreground and background model trained 
with a neural network. The automatic quantification results 
show a high correlation with manually measured CCM 
features (CNFL, CNFD and CNBD). The results also show 
significant differences (p-values of ANOVA test in table II) 
between the control and non-neuropathic group, indicating the 
system’s ability to detect early signs of change from a healthy 
to a diabetic condition. The automated system is able to 
produce additional CCM features that measure the area, width 
and orientation of the nerve fibres (CNFA, CNFWH and 
CNFOH). All these new measures show significant differences 
between the non-neuropathic and neuropathic groups (p-
values of ANOVA test in table III), with some features 
achieving 72% sensitivity-specificity at the equal error rate 
point, indicating the capacity to identify individuals suffering 
from neuropathy. The advantages in time labour and 
reproducibility suggest that automatically measured features 
may be used as a new, non-invasive method for diagnosing 
diabetic peripheral neuropathy, providing information on small 
nerve-fibre damage that is not accessible by most currently used 
methods. The only method in current clinical use that addresses 
small fibre damage is the intra-epidermal nerve-fibre density 
(IENFD) measure, which is invasive, requiring a skin biopsy, and 
currently cannot be evaluated automatically. We have recently 
shown [35] that analysis of CCM features has favourable 
diagnostic efficacy to IENFD (AUC of 0.66) 
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